Previous Article | Next Article ![]()
Molecular and Cellular Biology, June 2006, p. 4362-4367, Vol. 26, No. 11
0270-7306/06/$08.00+0 doi:10.1128/MCB.02163-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York 14263
Received 8 November 2005/ Returned for modification 10 January 2006/ Accepted 13 March 2006
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
yeasts are temperature sensitive for growth (7). Metazoan species with long, intron-containing genes are likely even more dependent on the physical coupling of transcriptional elongation and RNA processing for efficient gene expression. The presence of metazoan structural homologues for the yeast TREX proteins Tho2p (Thoc2), Sub2p (UAP56), and Yra1p (Aly) suggests that multicellular organisms utilize an analogous mechanism to link transcriptional elongation and RNA processing (12, 22, 24, 25). Although lacking statistically significant similarity at the primary amino acid level, functional orthologues of yeast Hpr1p have also been identified in both human and insect cells (alternatively known as Thoc1, hHpr1, or p84). Depletion of the Hpr1p orthologue from human cancer cell lines or insect cells compromises transcriptional elongation, nuclear RNA export, cell viability, and cell proliferation (11, 18). However, the subunit compositions of the yeast and metazoan TREX complexes are not identical, suggesting the possibility of functional or regulatory differences (13, 18). The physiological requirements for the various TREX proteins have yet to be assessed genetically in a metazoan species, so it is currently unknown whether TREX function is required for the normal growth and development of multicellular organisms. To address this limitation, we have generated a null allele of the murine Thoc1 gene. We describe the phenotypic characterization of mice containing this Thoc1 null allele.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Germ line-transmitting chimeras were generated by blastocyst injection of two independent, successfully targeted embryonic stem cell lines. Routine genotyping of genomic DNA extracted from tail biopsy specimens was performed with a PCR assay using the primers 5'TGCCGTAGAAAAATGCACAG3', 5'AACCACCCCTAATATTCTCCATC3', and 5'TAAAGCGCATGCTCCAGA3'. Genotyping of preimplantation embryos was performed using a nested-PCR assay. Individual embryos or cell outgrowths were lysed by incubation at 55°C for 4 h in 20 µl of PCR lysis buffer (10 mM Tris-HCl, pH 8.8, 50 mM KCl, 0.08% NP-40, 0.2 mM deoxynucleoside triphosphate, 2.5 mM MgCl2) containing proteinase K (60 µg/ml). After being boiled, an aliquot of the lysates was subjected to nested-PCR amplification using the first-round primers 5'TGCCGTAGAAAAATGCACAG3', 5'TAAGGTAACTAGAGAGGGAAAGTGTT3', and 5'TAAAGCGCATGCTCCAGA3'. The second-round primers were 5'GGATCCACTAGTTCTAGAGCGG3', 5'GTCTTCCCTTGTCACTGG3', and 5'AACCACCCCTAATATTCTCCATC3'. The null allele generates a 230-bp PCR fragment, while the wild-type allele produces a 527-bp fragment.
All animal work was approved by the Roswell Park Cancer Institute Institutional Animal Care and Use Committee and met federal guidelines.
RT-PCR. Total RNA was extracted from 30 embryos at each embryonic stage. The RNA was extracted with TRIzol according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). Reverse transcription (RT) was carried out using the SuperScript first-strand synthesis system for RT-PCR (Invitrogen, Carlsbad, CA). The cDNA was used as a template for PCR. PCR primers for mouse Thoc1 were N5-3 (5'-CTCACTTCTTCCAGCCAACC-3') and N5-4 (5'-AGGGAGCCAGAATCTTCCAT-3'). PCR of ß-actin cDNA using primers actin-1 (5'-GGCATCCTCACCCTGAAGTA-3') and actin-2 (5'-AGAGGCGTACAGGGATAGCA-3') was used as an input control. These primer sets gave rise to Thoc1 and ß-actin PCR fragments of 263 and 248 bp, respectively. The PCR products were resolved by 2% agarose gel electrophoresis and stained with ethidium bromide.
Preimplantation embryo culture. Timed pregnancies were used to generate preimplantation embryos for analysis. Thoc1 heterozygous females were given an intraperitoneal injection of pregnant mare's serum gonadotropin (5 IU per animal; Sigma-Aldrich, St. Louis, MO), followed 47 h later by an injection of human chorionic gonadotropin (5 IU per animal; Sigma-Aldrich, St. Louis, MO). Treated females were bred with heterozygous Thoc1 males, and the morning of detection of the vaginal plug was designated embryonic day 0.5 (E0.5). Preimplantation embryos (E1.5 to E4.0) were collected by flushing the oviduct or uterus with HEPES-buffered medium 2 (M2; Sigma-Aldrich, St. Louis, MO). For in vitro culture, embryos were cultured in M16 medium without leukemia inhibitory factor.
Immunostaining. Preimplantation embryos were washed in 4 mg/ml of bovine serum albumin/phosphate-buffered saline (BSA/PBS) and then fixed for 30 min at 37°C in 3% paraformaldehyde in stabilization buffer [0.l M piperazine-N,N'-bis(2-ethanesulfonic acid), 5 mM MgCl2, and 2.5 mM EGTA]. The embryos were rinsed two times in BSA/PBS, transferred to 0.2% Triton in BSA/PBS at room temperature for 45 min, and then blocked overnight in 3% fetal calf serum, 0.1% Tween-20, 0.02% Na-azide, 0.4% powdered milk. The embryos were then incubated in the primary antibody for 1 h at 37°C, washed, and incubated with secondary antibody for an additional hour at 37°C. Immunostaining was performed using primary antibodies directed against Thoc1 protein (pThoc1) (5E10; Genetex, San Antonio, TX), activated caspase 3 (9661; Cell Signaling, Beverly, MA), Oct4 (Santa Cruz Biotechnology, Santa Cruz, CA), and serine 10 phosphorylated histone H3 (06-570; Upstate, Waltham, MA). Fluorescent secondary antibodies and the DNA counterstain Hoechst 33342 were from Molecular Probes (Carlsbad, CA). Whole E12.5 embryos were frozen, fixed, and sectioned as previously described (8) and then immunostained for pThoc1 and counterstained for DNA as described above. Overlapping fluorescent images were captured using a 10x objective on a Zeiss Axioplan2 microscope. Individual images were merged using Adobe Photoshop to generate the whole-embryo composite image.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
|
|
|
Consistent with the interrogation of gene expression databases, we find that Thoc1 RNA is present in the fertilized oocyte and throughout preimplantation embryonic development (Fig. 3A). Thoc1 protein is also widely expressed at later stages of development. Sagittal sections of E12.5 wild-type embryos have been immunostained for pThoc1, and nuclear pThoc1 staining is observed in all tissues and cell types that are detectable in such sections (Fig. 3B). Similar results are observed in E13.5 embryos (data not shown). We conclude that Thoc1 is widely expressed during embryonic development. Thoc1 expression has previously been detected in a wide range of adult tissues (5).
|
The blastocyst stage marks segregation into the first two cell lineages in the mammalian embryo, the ICM, comprised of undifferentiated embryonic stem cells that ultimately give rise to the embryo proper, and the differentiating trophoectoderm (TE), which contributes to extraembryonic tissues, like the placenta. We immunostained blastocysts for the differentiation markers Oct4 (ICM) and Cdx2 (TE) to determine if cellular differentiation occurs in Thoc1/ blastocysts and to identify which cell type fails to accumulate. As expected, wild-type late-stage blastocysts showed a well-organized inner cell mass comprised of cells expressing Oct4, but not Cdx2 (Fig. 4). Cells comprising the presumptive TE of Thoc1-expressing blastocysts express Cdx2, but not Oct4. In contrast to wild-type blastocysts, there were very few Oct4-positive cells in age-matched Thoc1/ embryos, and a well-organized inner cell mass was not apparent (Fig. 4A). However, the few Oct4-positive cells observed were Cdx2 negative. The presumptive TE of Thoc1/ blastocysts contained approximately normal numbers of Cdx2-positive and Oct4-negative cells in the appropriate spatial organization (Fig. 4B). Proper cellular differentiation of the TE in Thoc1/ blastocysts is also supported by the appearance of the blastocoel cavity, which requires formation of adherens junctions and tight junctions, the apparent initiation of a decidual reaction (see above), and normal-appearing E-cadherin staining (data not shown). These data suggest that cellular differentiation is properly initiated in Thoc1/ embryos but that Oct4-positive Cdx2-negative cells of the ICM fail to survive. We conclude that Thoc1 deficiency causes peri-implantation embryonic lethality due initially to the failure of Oct4-positive cells of the ICM to survive.
|
The mammalian TREX component pThoc1 is essential for the viability of at least some cell types in mice. Given that murine pThoc1 has a high degree of primary amino acid sequence similarity to pThoc1 from other metazoan species, the requirement for pThoc1 is likely to extend to other multicellular organisms. For example, Drosophila melanogaster and human cancer cell lines both exhibit reduced viability upon depletion of their respective orthologous Thoc1 proteins (11, 18). In contrast, HPR1 is not essential for the viability of the unicellular yeast S. cerevisiae, although Hpr1p-deficient yeasts grow more slowly, are temperature sensitive for growth, and have a reduced cellular life span (14, 20). The differences in the physiological requirements for HPR1/Thoc1 may reflect TREX-independent functions of pThoc1 or may be due to differences in the functions of the yeast and metazoan TREX complexes. While all detectable pThoc1 is resident within TREX complexes (13), we currently cannot exclude the possibility that TREX independent functions are responsible for the pThoc1 requirement for cell viability. Since the yeast and metazoan TREX complexes differ in subunit composition, we favor the second hypothesis, that metazoan TREX complexes may have functions and regulatory inputs distinct from their yeast counterpart and that these differences account for the different physiological requirements for HPR1/Thoc1. Resolution of this issue will require further comparison of the molecular, cellular, and physiological functions of the yeast and metazoan TREX complexes.
| ACKNOWLEDGMENTS |
|---|
This work was supported by grants to D.W.G. from the National Cancer Institute (CA-70292) and the Ralph C. Wilson Foundation Medical Research Foundation. National Cancer Institute Cancer Center Support Grant CA016056 supported the Cell Analysis and Transgenic Mouse facilities utilized in this work.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Chavez, S., and A. Aguilera. 1997. The yeast HPR1 gene has a functional role in transcriptional elongation that uncovers a novel source of genome instability. Genes Dev. 11:3459-3470.
3. Chavez, S., T. Beilharz, A. G. Rondon, H. Erdjument-Bromage, P. Tempst, J. Q. Svejstrup, T. Lithgow, and A. Aguilera. 2000. A protein complex containing Tho2, Hpr1, Mft1 and a novel protein, Thp2, connects transcription elongation with mitotic recombination in Saccharomyces cerevisiae. EMBO J. 19:5824-5834.[CrossRef][Medline]
4. Chavez, S., M. Garcia-Rubio, F. Prado, and A. Aguilera. 2001. Hpr1 is preferentially required for transcription of either long or G+C-rich DNA sequences in Saccharomyces cerevisiae. Mol. Cell. Biol. 21:7054-7064.
5. Durfee, T., M. A. Mancini, D. Jones, S. J. Elledge, and W.-H. Lee. 1994. The amino-terminal region of the retinoblastoma gene product binds a novel nuclear matrix protein that co-localizes to centers for RNA processing. J. Cell Biol. 127:609-622.
6. Fan, H. Y., K. K. Cheng, and H. L. Klein. 1996. Mutations in the RNA polymerase II transcription machinery suppress the hyperrecombination mutant hpr1 delta of Saccharomyces cerevisiae. Genetics 142:749-759.[Abstract]
7. Fan, H. Y., R. J. Merker, and H. L. Klein. 2001. High-copy-number expression of Sub2p, a member of the RNA helicase superfamily, suppresses hpr1-mediated genomic instability. Mol. Cell. Biol. 21:5459-5470.
8. Frey, M. R., J. A. Clark, O. Leontieva, J. M. Uronis, A. R. Black, and J. D. Black. 2000. Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium. J. Cell Biol. 151:763-778.
9. Huertas, P., and A. Aguilera. 2003. Cotranscriptionally formed DNA:RNA hybrids mediate transcription elongation impairment and transcription-associated recombination. Mol. Cell 12:711-721.[CrossRef][Medline]
10. Krogan, N. J. D. 2003. The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation. Mol. Cell 11:721-729.[CrossRef][Medline]
11. Li, Y., X. Wang, X. Zhang, and D. W. Goodrich. 2005. Human hHpr1/p84/Thoc1 regulates transcriptional elongation and physically links RNA polymerase II and RNA processing factors. Mol. Cell. Biol. 25:4023-4033.
12. Luo, M. L., Z. Zhou, K. Magni, C. Christoforides, J. Rappsilber, M. Mann, and R. Reed. 2001. Pre-mRNA splicing and mRNA export linked by direct interactions between UAP56 and Aly. Nature 413:644-647.[CrossRef][Medline]
13. Masuda, S., R. Das, H. Cheng, E. Hurt, N. Dorman, and R. Reed. 2005. Recruitment of the human TREX complex to mRNA during splicing. Genes Dev. 19:1512-1517.
14. Merker, R. J., and H. L. Klein. 2002. hpr1Delta affects ribosomal DNA recombination and cell life span in Saccharomyces cerevisiae. Mol. Cell. Biol. 22:421-429.
15. Moore, M. J. 2005. From birth to death: the complex lives of eukaryotic mRNAs. Science 309:1514-1518.
16. Ng, H. H., S. Dole, and K. Struhl. 2003. The Rtf1 component of the Paf1 transcriptional elongation complex is required for ubiquitination of histone H2B. J. Biol. Chem. 278:33625-33628.
17. Reed, R. 2003. Coupling transcription, splicing and mRNA export. Curr. Opin. Cell Biol. 15:326-331.[CrossRef][Medline]
18. Rehwinkel, J., A. Herold, K. Gari, T. Kocher, M. Rode, F. L. Ciccarelli, M. Wilm, and E. Izaurralde. 2004. Genome-wide analysis of mRNAs regulated by the THO complex in Drosophila melanogaster. Nat. Struct. Mol. Biol. 11:558-566.[CrossRef][Medline]
19. Rondon, A. G., S. Jimeno, M. Garcia-Rubio, and A. Aguilera. 2003. Molecular evidence that the eukaryotic THO/TREX complex is required for efficient transcription elongation. J. Biol. Chem. 278:39037-39043.
20. Santos-Rosa, H., and A. Aguilera. 1994. Increase in incidence of chromosome instability and non-conservative recombination between repeats in Saccharomyces cerevisiae hpr1 delta strains. Mol. Gen. Genet. 245:224-236.[Medline]
21. Soukharev, S., J. L. Miller, and B. Sauer. 1999. Segmental genomic replacement in embryonic stem cells by double lox targeting. Nucleic Acids Res. 27:e21.
22. Strasser, K., and E. Hurt. 2000. Yra1p, a conserved nuclear RNA-binding protein, interacts directly with Mex67p and is required for mRNA export. EMBO J. 19:410-420.[CrossRef][Medline]
23. Strasser, K., S. Masuda, P. Mason, J. Pfannstiel, M. Oppizzi, S. Rodriguez-Navarro, A. G. Rondon, A. Aguilera, K. Struhl, R. Reed, and E. Hurt. 2002. TREX is a conserved complex coupling transcription with messenger RNA export. Nature 417:304-308.[CrossRef][Medline]
24. Stutz, F., A. Bachi, T. Doerks, I. C. Braun, B. Seraphin, M. Wilm, P. Bork, and E. Izaurralde. 2000. REF, an evolutionary conserved family of hnRNP-like proteins, interacts with TAP/Mex67p and participates in mRNA nuclear export. RNA 6:638-650.[Abstract]
25. West, R. W., Jr., B. Kruger, S. Thomas, J. Ma, and E. Milgrom. 2000. RLR1 (THO2), required for expressing lacZ fusions in yeast, is conserved from yeast to humans and is a suppressor of SIN4. Gene 243:195-205.[CrossRef][Medline]
26. Wood, A., J. Schneider, J. Dover, M. Johnston, and A. Shilatifard. 2003. The Paf1 complex is essential for histone monoubiquitination by the Rad6-Bre1 complex, which signals for histone methylation by COMPASS and Dot1p. J. Biol. Chem. 278:34739-34742.
27. Zenklusen, D., P. Vinciguerra, J. C. Wyss, and F. Stutz. 2002. Stable mRNP formation and export require cotranscriptional recruitment of the mRNA export factors Yra1p and Sub2p by Hpr1p. Mol. Cell. Biol. 22:8241-8253.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|